Partners Capital Investment Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,605
Closed -$266K 160
2023
Q4
$266K Sell
4,605
-141
-3% -$7.53K 0.01% 239
2023
Q3
$251K Buy
+4,746
New +$249K 0.01% 213
2021
Q4
Sell
-2,604
Closed -$113K 124
2021
Q3
$113K Sell
2,604
-53,298
-95% -$2.36M 0.01% 120
2021
Q2
$2.39M Sell
55,902
-602,796
-92% -$25.4M 0.11% 102
2021
Q1
$25.5M Buy
658,698
+67,056
+11% +$2.54M 1.12% 31
2020
Q4
$21.3M Buy
591,642
+168,804
+40% +$6.08M 1.22% 34
2020
Q3
$16.2M Buy
422,838
+85,340
+25% +$3.29M 1% 35
2020
Q2
$11.8M Buy
+337,498
New +$12.2M 0.58% 47

Other funds holding BSX

Partners Capital Investment Group's BSX Position: Q1 2024 in Review

Partners Capital Investment Group sold out of Boston Scientific (BSX) in Q1 2024, closing a stake of 4,605 shares — an estimated $266K sold.

Partners Capital Investment Group first reported a position in BSX in Q2 2020 and held it in 8 quarters. The position peaked at $25.5M in Q1 2021. 1,223 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

  • Partners Capital Investment Group reported no remaining Boston Scientific position as of Q1 2024 after selling out during the quarter.
  • Partners Capital Investment Group sold 4,605 Boston Scientific shares in Q1 2024, an estimated $266K.
  • Partners Capital Investment Group first reported a position in Boston Scientific in Q2 2020 and held it in 8 quarters.
  • Partners Capital Investment Group's Boston Scientific position peaked at $25.5M in Q1 2021.
  • 1,223 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Partners Capital Investment Group's 13F filing for Q1 2024, filed 14 May 2024.